What laboratory tests and immunizations are recommended for a healthy 17‑year‑old female during her routine wellness visit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Labs and Vaccines for a 17-Year-Old Female at Wellness Visit

A 17-year-old female at her wellness visit should receive HPV vaccine (if not completed), Tdap (if not received), meningococcal vaccines (MenACWY booster and MenB based on shared decision-making), annual influenza vaccine, and catch-up vaccines as needed; routine laboratory screening should include annual chlamydia testing and consideration for gonorrhea screening based on sexual activity and risk factors.

Immunizations

Priority Vaccines

HPV Vaccination (Highest Priority)

  • Administer HPV vaccine series if not completed 1, 2
  • The 3-dose series should be completed by age 26 years for catch-up vaccination
  • Doses given at 0,2 months, and 6 months (minimum intervals: 4 weeks between doses 1-2, and 12 weeks between doses 2-3)
  • No pre-vaccination testing for HPV DNA, HPV antibody, or Pap testing is needed 1
  • Sexual activity status does not preclude vaccination—even sexually active females benefit from protection against HPV types they haven't encountered 1

Tdap Vaccine

  • Verify receipt of Tdap booster (should have been given at age 11-12 years) 2
  • If not received, administer now
  • Tdap can be given regardless of interval since last tetanus-containing vaccine 2

Meningococcal Vaccines

  • MenACWY booster dose at age 16-17 years if first dose was given at age 11-12 years 2, 3, 4
  • MenB vaccine series can be offered through shared clinical decision-making for ages 16-23 years (preferred age 16-18 years) 2, 4, 5
    • Two-dose series depending on formulation
    • Particularly consider for college-bound students, those in congregate living settings

Annual Influenza Vaccine

  • Administer current season's influenza vaccine 3, 4

Catch-Up Vaccines (If Incomplete)

Review immunization record and complete any missing vaccines:

  • Hepatitis B series (3 doses) if not completed 3
  • Hepatitis A series (2 doses) - now recommended for all adolescents through age 18 years 3, 4
  • MMR (2 doses) if not documented 2
  • Varicella (2 doses) if no history of disease and not previously vaccinated 2

Laboratory Screening

Sexually Transmitted Infection Screening

Chlamydia Screening (Essential)

  • Screen annually for Chlamydia trachomatis in all sexually active females aged ≤25 years 6
  • Use nucleic acid amplification test (NAAT) on urine or vaginal swab
  • Rescreen 3 months after treatment if positive, regardless of partner treatment status 6

Gonorrhea Screening

  • Screen annually for gonorrhea in sexually active females 6
  • Consider screening every 3-6 months if high-risk factors present:
    • Multiple or anonymous partners
    • Sex in conjunction with illicit drug use
    • New partner
    • History of previous STI
    • Inconsistent condom use

Risk-Based Screening

  • Trichomoniasis: Not routine, but consider if high-risk factors (multiple partners, history of STIs, exchanging sex for payment) 6
  • Syphilis: Not routine for heterosexual adolescents, but screen if high-risk behaviors present 6
  • HIV: Offer screening based on sexual activity and risk assessment

Other Laboratory Tests

No routine laboratory tests are universally recommended for healthy 17-year-old females at wellness visits beyond STI screening in sexually active individuals. Additional testing should be based on:

  • Individual risk factors
  • Family history
  • Specific clinical concerns
  • Sexual activity status

Critical Implementation Points

Common Pitfalls to Avoid

  1. Missing HPV vaccination opportunities: At age 17, this is catch-up vaccination—don't delay further 1, 4
  2. Forgetting MenACWY booster: The 16-year booster is frequently missed 4, 5
  3. Not screening sexually active females for chlamydia: This is the highest-burden STI in this age group 6
  4. Assuming sexual activity status: Take a confidential, non-judgmental sexual history to guide STI screening 6

Documentation Needed

  • Review immunization records from childhood
  • Verify dates of previous vaccines to determine appropriate intervals
  • Document sexual history confidentially (separate from parent discussion if minor laws permit)
  • Assess for high-risk behaviors requiring enhanced STI screening

Nuances in Evidence

The guidelines consistently prioritize HPV vaccination through age 26 for catch-up, with multiple ACIP recommendations emphasizing that even sexually active adolescents benefit 1, 2. Recent surveillance data show HPV vaccination rates lag significantly behind other adolescent vaccines (58.6% up-to-date in 2020 vs. 90.1% for Tdap) 4, making this a critical intervention opportunity.

For STI screening, the evidence strongly supports routine chlamydia screening in all sexually active females ≤25 years, with gonorrhea screening based on individual and community prevalence 6. The 3-month rescreening recommendation after positive tests reflects high reinfection rates in this population.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.